Cite
HARVARD Citation
Prejac, J. et al. (2022). The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence. Medicine. 101 (39), pp. e30566-. [Online].